Log in

LON:NSCINetscientific Share Price, Forecast & News

GBX 5.88
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: GBX 5.88
50-Day Range
MA: GBX 6.50
52-Week Range
Now: GBX 5.88
Volume321,764 shs
Average Volume4,986 shs
Market Capitalization£4.62 million
P/E RatioN/A
Dividend YieldN/A
NetScientific plc is a venture capital firm specializing in seed, early and mid stage investments. The firm focuses to invest in transformative biomedical and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets and in the United States. It typically invests up to $15 million, but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. NetScientific plc was founded in 2008 and is based in London, United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.65 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual Sales£735,000.00
Cash FlowGBX 4.31 per share
Book ValueGBX 7 per share



Market Cap£4.62 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NSCI News and Ratings via Email

Sign-up to receive the latest news and ratings for NSCI and its competitors with MarketBeat's FREE daily newsletter.

Netscientific (LON:NSCI) Frequently Asked Questions

How has Netscientific's stock been impacted by COVID-19 (Coronavirus)?

Netscientific's stock was trading at GBX 2 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NSCI stock has increased by 193.8% and is now trading at GBX 5.88. View which stocks have been most impacted by Coronavirus.

How were Netscientific's earnings last quarter?

Netscientific PLC (LON:NSCI) announced its earnings results on Monday, April, 27th. The company reported ($4.30) earnings per share (EPS) for the quarter. View Netscientific's earnings history.

Has Netscientific been receiving favorable news coverage?

Press coverage about NSCI stock has trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Netscientific earned a news impact score of 0.7 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Netscientific.

Who are some of Netscientific's key competitors?

What other stocks do shareholders of Netscientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Netscientific investors own include Travelzoo (TZOO), TRACON Pharmaceuticals (TCON), Summit Industrial Income REIT (SMU.UN), Opko Health (OPK), Hvivo (HVO), Habit Restaurants (HABT), Catasys (CATS) and Best Buy (BBY).

Who are Netscientific's key executives?

Netscientific's management team includes the following people:
  • Mr. Douglas R. Delp, CEO, MD & Director
  • Ian David Postlethwaite, CFO, Corp. Sec. & Director (Age 56)
  • Stephen D. Crowe, Group Financial Controller
  • Dr. Frank K. Bedu-Addo, Chief Exec. Officer of PDS Biotechnology (Age 54)
  • Mr. Alexander Patel, Analyst of Investments

What is Netscientific's stock symbol?

Netscientific trades on the London Stock Exchange (LON) under the ticker symbol "NSCI."

How do I buy shares of Netscientific?

Shares of NSCI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Netscientific's stock price today?

One share of NSCI stock can currently be purchased for approximately GBX 5.88.

How big of a company is Netscientific?

Netscientific has a market capitalization of £4.62 million and generates £735,000.00 in revenue each year. Netscientific employs 41 workers across the globe.

What is Netscientific's official website?

The official website for Netscientific is netscientific.net.

How can I contact Netscientific?

Netscientific's mailing address is 30 St. Mary Axe, LONDON, EC3A 8BF, United Kingdom. The company can be reached via phone at +44-20-35141800.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.